Methotrexate, rheumatoid arthritis and infection risk: what is the evidence?
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 19447771.
- Also identified by DOI 10.1093/rheumatology/kep101.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Low-dose MTX administered weekly remains a mainstay in the therapy of RA. There is a belief amongst rheumatologists that RA patients taking MTX have both an increased risk and severity of infection. Here we review the published data on the risks of infection associated with the use of MTX in patients with RA and make some recommendations for managing MTX in patients with infection.
Medical subject headings
- Antirheumatic Agents
- Arthritis, Rheumatoid
- Bacterial Infections
- Immunosuppressive Agents
- Methotrexate